NEWS

Lacivert bir takım elbise giymiş ve gözlüklü bir adam, arkasında bir Dell bilgisayar ve kağıt yığınları bulunan modern bir ofiste duruyor ve doğrudan izleyiciye bakıyor.

Mataró firm Minoryx gets EU approval for therapy for fatal childhood disease

The pharmaceutical company Minoryx, based in Mataró, has secured European Union approval for a unique therapy targeting a fatal childhood neurodegenerative disease. This approval provides a new treatment option for families affected by this condition.

This is a news summary compiled for the İyi Giden Şeyler newsletter — not the original article. The original article is at pharmaphorum.com.

Read the original article English (automatic translation)

Back to the issue